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Chemometric methodsAbstract Simple, accurate sensitive and precise spectrophotometric and chemometric stability
indicating techniques were adopted for the determination of Pimozide (PIM) in presence of its alka-
line and acidic degradation products over a concentration range of 10–100 lg mL1. The proposed
spectrophotometric technique includes ﬁrst derivative (D1) spectrophotometric one at 252 nm and
256.6 nm in presence of its acidic and alkaline degradates, respectively, ﬁrst-derivative of the ratio
spectra spectrophotometry (DR1) at 292.5 nm, the Q-analysis (absorption ratio) method, which
involves the formation of absorbance equation at 242.2 nm and 281.7 nm, dual wave length method
at 270.1 nm and 284 nm, the H-point standard addition method (HPSAM) and the mean centering
of the ratio spectra method. The second technique is chemometric methods which include determi-
nation of PIM in presence of both its acidic and alkaline degradates using multivariate calibration
methods [the classical least squares (CLS), principle component regression (PCR) and partial least
squares (PLS)] using the information contained in the absorption spectra. The proposed methods
have been successfully applied to the analysis of PIM in pharmaceutical dosage forms without inter-
ference from other dosage form additives and the results were statistically compared with the ofﬁcial
method.
 2015 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Pimozide; 1-[1-[4, 4-bis (4-ﬂuorophenyl) butyl]-4-piperidinyl]-1,
3-dihydro-2H-benzimidazole-2-one 1 (Fig. 1). PIM is a neu-
roleptic of the diphenyl butyl piperidine series. It is a potent
Figure 1 Chemical structure of intact Pimozide.
174 A.M.A.A. Alamein et al.long-acting anti-psychotic, used mainly to control effectively
hallucinations and delusions and to normalize incoherent
thought processes and bizarre behavior patterns.2 PIM
appears to undergo signiﬁcant ﬁrst pass metabolism. The
major route of elimination of its metabolites is via the kidney.2
PIM is ofﬁcial in British Pharmacopoeia.3 PIM was
determined by several analytical techniques including;
spectroscopic methods either colorimetric,4–6 or ﬂuorimetric7
methods. PIM can also be determined by electrochemical
methods,8 and HPTLC.9 High performance liquid chromato-
graphic [HPLC] methods were widely used for analysis of
PIM.10–17
To the best of our Knowledge, only one stability indicating
HPTLC method9 was reported for pimozide and no other
spectrophotometric or chemometric stability indicating tech-
niques was proposed for the determination of PIM in presence
of its alkaline and acidic degradation products. So the aim of
the present study is to develop and validate simple, accurate
and speciﬁc stability indicating method for the quantiﬁcation
of pimozide in the presence of its degradation products.
2. Experimental
2.1. Instrumentation
A double beam UV–VIS spectrophotometer (UV-1800, Japan)
connected to IBM compatible computer. The bundled soft-
ware is UV probe software version 2.32 (Shimadzu) and the
spectral bandwidth was 0.1 nm. The absorption spectra were
carried out using 1 cm quartz cells. The chemometric
calculations were performed in Matlab for Windows-version
7 Mathworks Inc. 2004. The PLS procedure was taken from
PLS Toolbox 2.0, Eigenvector Research Inc. 2001 created by
B.M. Wise, N.B. Gallagher for use with Matlab.
2.2. Materials and reagents
All chemicals were of analytical grade, the solvents were of
spectroscopic grade.
PIM was purchased from Sigma Aldrich. Its purity was
100.09%± 0.14 (n= 5) according to the ofﬁcial non aqueous
titration.3
Orape forte4 mg tablets, labeled to contain 4 mg of PIM
per tablet were manufactured by Janssen Cilag, Batch No.
12CQ019 and purchased from the Egyptian market.
Sodium hydroxide, hydrochloric acid (Adwic-Cairo,
Egypt), and methanol (Analar-Germany) were used.2.3. Standard solutions of the intact Pimozide
2.3.1. Stock solution
A standard stock solution of PIM was prepared by transfer-
ring accurately 100 mg of pure drug into 100-mL volumetric
ﬂask, dissolving in 20 mL methanol with the aid of sonication
and then the volume was completed to the mark with the same
solvent to provide standard stock solution containing
1 mg mL1.
2.3.2. Working solution
PIM working solution was prepared by transferring 10 mL of
the standard stock solution into 100-mL volumetric ﬂask and
then the volume was completed to the mark with methanol
to obtain standard working solution containing 0.1 mg mL1.
2.4. Preparation of standard solution of acidic and alkaline
degraded PIM
Methanolic PIM solutions containing accurately measured
50 mg were mixed with 25 mL of 2 M HCl and 2 M NaOH,
separately then reﬂuxed for 4 h. The solutions were cooled to
room temperature, neutralized with 2 M NaOH and 2 M
HCl, respectively till pH 7. Then the degradation products
were extracted with multiple fractions of methanol
(3  10 mL), then quantitatively transferred into 50 mL volu-
metric ﬂasks and the volume was completed with methanol
to reach concentration 1.00 mg mL1. Aliquot portions of
these solutions were diluted with methanol to prepare working
standard solutions of 0.1 mg mL1.
Complete acidic and alkaline degradation of the studied
drug was conﬁrmed by the TLC method using toluene: ace-
tone: ammonia (5:5:0.1 by volume)9 where no peaks corre-
sponding to intact drug were detected in case of the
degraded samples. The degradates were elucidated by IR
spectrometry.
2.5. Procedures
2.5.1. Construction of calibration curves for D1
spectrophotometric method
Accurately measured volumes of intact PIM working solution
(0.1 mg mL1) were transferred into a series of 10-mL volu-
metric ﬂasks and diluted to the mark with methanol to obtain
concentrations from 10 to100 lg mL1. The D1 spectra of each
solution were recorded using Dk= 8 and scaling factor = 100.
For determination of PIM in presence of its acidic and alkaline
degradates, calibration curves were obtained by plotting the
peak amplitudes of D1 at 252 nm and 256.6 nm respectively
(corresponding to zero-crossing of the degradation product)
versus the corresponding drug concentrations, and regression
equations were computed.
2.5.2. Construction of calibration curves of (DD1)
spectrophotometric method
Different aliquots of intact PIM working solution
(0.1 mg mL1) were accurately transferred into a series of
10 mL volumetric ﬂasks and diluted to the mark with metha-
nol to obtain concentrations from 10 to100 lg mL1. The
DD1curves were recorded at Dk= 8 and scaling factor = 10.
Table 1 The concentration of mixtures of PIM, and both its
acidic and alkaline degradate in the training set.
Sample
no.
PIM
(lg mL1)
Alkaline degradate
(lg mL1)
Acidic degradate
(lg mL1)
1 40 40 40
2 40 20 20
3 20 60 30
4 60 30 60
5 60 40 30
6 40 30 30
7 30 50 60
8 50 60 50
9 50 40 60
10 40 60 60
11 60 20 50
12 20 50 20
13 20 40 50
14 40 50 50
15 50 30 20
16 30 20 30
Univariate spectrophotometry and multivariate calibration 175The absorption spectra of these solutions were divided by the
absorption spectrum of 80 lg mL1 of the acidic and
20ug mL1of the alkaline degradates separately (as divisors).
The obtained ratio spectra were then differentiated with
respect to wave length. The peak amplitudes at 292.5 nm were
recorded for the determination of PIM in presence of either its
acidic or alkaline degradates. The calibration curves represent-
ing the relationship between the measured amplitudes and the
corresponding concentrations of the drug were constructed
and the regression equations were computed.
2.5.3. Construction of calibration curves for Q-analysis
(absorption ratio) method
Accurately measured volumes of intact PIM and its alkaline
degradates working solutions were transferred separately into
a series of 10-mL volumetric ﬂasks and diluted to the mark
with methanol to obtain concentrations from 10 to
100 lg mL1.The Zero-order spectrum of each dilution was
recorded against methanol as a blank. The absorbance of
PIM and its alkaline degradates was measured at 242.2 nm
(isobestic point) and 281.7 nm (kmax of PIM) for each dilution
separately. Then the absorbances at the selected wavelengths
were plotted against the corresponding concentrations and
the regression equations were then computed. Absorptivity
coefﬁcients of PIM and its alkaline degradation product were
determined at both selected wavelengths; the absorption equa-
tion was then formed. The concentration of the drug of interest
is calculated from the equation.
2.5.4. Construction of calibration curve for dual wavelength
method
Accurately measured volumes of intact PIM working solution
(0.1 mg mL1) were transferred into a series of 10-mL volu-
metric ﬂasks and diluted to the mark with methanol to obtain
concentrations from 10 to 100 lg mL1. The Zero-order spec-
trum of each dilution was recorded against methanol as a
blank. The absorbance of PIM was measured at 270.1 nm
and 284 nm for each dilution separately. Then the difference
between the absorbance at the selected wavelengths wascalculated, plotted against the corresponding concentrations
of the drug and the regression equation was then computed.
2.5.5. Construction of calibration curves for H-point standard
addition analysis method
Synthetic samples containing different ratios of PIM and its
alkaline degradates were prepared by transferring aliquots
equivalent to 100 lg of PIM and its alkaline degradate into a
set of 10-mL volumetric ﬂasks from their respective working
solutions, a standard addition of different aliquots of PIM in
the range of 10–80 lg was added to the previously prepared
synthetic samples and the volume was completed to the mark
with methanol. The zero order absorption spectra of the pre-
pared mixtures were recorded against methanol as a blank.
The peak amplitudes were measured at 270.1 nm and 284 nm
for each dilution separately, and then plotted against the cor-
responding added PIM concentrations .The regression equa-
tion was then computed.
2.5.6. Construction of calibration curve for mean centering
spectrophotometric method
Accurately measured volumes of PIM working solution were
transferred into a series of 10-mL volumetric ﬂasks and diluted
to the mark with methanol to obtain concentrations from 10 to
100 lg mL1. The Zero-order spectrum of each dilution was
recorded against methanol as blank and stored. The stored
spectra and a standard spectrum of the alkaline degradation
product (20 lg mL1) were transferred to Matlab, then each
spectrum of the drug was divided by the standard spectrum of
the degradation product, Mean centering of these vectors
(spectra) with respect to wavelength was done and the mean
centered curves were obtained .The values of the curves were
recorded at 284 nm corresponding to a maximum wavelength,
plotted each against its corresponding concentration and the
regression parameters were computed.
2.5.7. Multivariate calibration technique (chemometric)
(a) Construction of training set: Different mixtures of PIM
and its acidic and alkaline degradation product were
prepared by diluting different volumes of their stock
standard solutions into 10-mL volumetric ﬂask. The vol-
ume was completed to the mark with methanol to reach
the concentrations listed in Table 1. The absorbance of
these mixtures was measured between 230 and 470 nm
at 1 nm interval with respect to a blank of methanol.
The composition of the samples was randomly designed
according to ﬁve level calibration designs in order to
obtain non correlated concentration proﬁles and this
calibration design prepared to obey Beer’s law.
(b) Construction of the models: To build the CLS model,
feed the computer with absorbance and concentration
matrices for training set. Carry out the calculations to
obtain the ‘‘K” matrix. For the PCR and PLS models,
use the training set absorbance and concentration matri-
ces together with PLS-Toolbox 2.0 software for the
calculations.
(c) Construction of the validation set: Prepare nine different
mixtures of PIM and its acidic and alkaline degradates
by transferring different volumes of their working stan-
dard solutions into a series of 10-mL volumetric ﬂasks
Table 2 The concentration of mixtures of PIM and both its
acidic and alkaline degradates in the validation set.
Sample
no.
PIM
(lg mL1)
Alkaline degradate
(lg mL1)
Acidic degradate
(lg mL1)
1 20 20 60
2 30 60 40
3 30 30 50
4 60 50 40
5 60 60 20
6 50 20 40
7 50 50 30
8 20 30 40
9 30 40 20
176 A.M.A.A. Alamein et al.and complete to volume with methanol, Table 2. Apply
the developed models to predict the concentration of
PIM in each mixture.
2.5.8. Laboratory prepared mixtures
Two solution sets containing different ratios of PIM and up to
60% of its acidic degradates in one set and up to 60% of its
alkaline degradates in the other set were prepared. The solu-
tion mixtures were analyzed by the proposed methods for
the determination of intact PIM in the presence of its acidic
and alkaline degradation products.
2.5.9. Application to pharmaceutical preparation
Ten tablets were accurately weighed and ﬁnely powdered. A
portion equivalent to 50 mg of PIM was weighed, sonicated
in 20 mL methanol and ﬁltered into 50-mL volumetric ﬂask.
The residue was washed three times each with 8 mL methanol
and completed to the mark with the same solvent. Aliquots
(according to linearity) were transferred to 10-mL volumetric
ﬂasks and diluted with methanol. The general procedures were
followed and the concentration of PIM was calculated from its
corresponding regression equation.3. Results and discussion
The International Conference on Harmonization (ICH) guide-
line entitled ‘‘stability testing of new drugs substances and
products” requires the stress testing of new substances and
products, also requires the stress testing to be carried out to
elucidate the inherent stability, characteristics of the active
substance.18 An ideal stability indicating method is one that
quantiﬁes the standard drug alone and also resolves its degra-
dation products. PIM hydrolyzed under alkaline and acid con-
ditions where complete degradation was observed using 2 M
NaOH and 2 M HCl after reﬂuxing for 4 h, respectively.
The structures of the intact drug, acidic and alkaline degra-
dates were elucidated by IR (Fig. 2(a)–(c)). Considering the IR
elucidation; it is suggested that complete hydrolysis of amide
NH-group was achieved. Where IR spectrum of intact PIM
showed a characteristic band at 3361.6 cm1 indicating the
presence of amide NH-group, and a band at 2940.1 cm1indi-
cating the presence of alkane C–H bonds and another charac-
teristic peak at 1643.0 cm1 indicating the presence of C‚O of
the amide group. While IR spectrum of the acidic degradates
showed a characteristic broad band at 3463.1 cm1, indicating
the presence of OH group while the appearance of a band at
1639.2 cm1 suggests the presence of C‚O of the carboxylic
acid. IR spectrum of the alkaline degradates showed a charac-
teristic broad band at 3463.1 cm1, indicating the presence of
OH group while the appearance of a band at 1639.2 cm1 sug-
gests the presence of C‚O of the carboxylic acid.
The focus of the present work was to develop accurate,
speciﬁc, reproducible and sensitive stability indicating methods
for the determination of PIM in pure form, in pharmaceutical
formulation, and in the presence of its acidic and alkaline
degradates.
The Zero-order absorption spectrum of PIM and its acidic
and alkaline degradates showed severe overlapping (Figs. 3
and 4) which interferes with the direct determination of PIM.3.1. Derivative spectrophotometry
The advantages of derivative spectrophotometry (Dn) are
enhanced resolution of overlapping peaks for separation of
superposed spectra particularly in multicomponent analysis
and background absorption minimization or elimination.
A rapid, simple and low cost spectrophotometric method
based on measuring the peak amplitude of D1 at 252 nm
(Fig. 5) and 256.6 nm (Fig. 6) was developed for determination
of PIM in presence of its acidic and alkaline degradates,
respectively (corresponding to zero crossing of the degradates)
with good selectivity without interference of its acidic and
alkaline degradates over concentration range of 10–
100 lg mL1.
In order to optimize D1 methods, different smoothing and
scaling factors were tested, where a smoothing factor Dk= 8
and scaling factor = 100 showed a suitable signal to noise
ratio and the spectra showed good resolutions.
3.2. DR1 method
In order to improve the selectivity of the analysis of PIM in
presence of its acidic and alkaline degradates DR1 method
was established.
The main advantage of the method is that the whole spec-
trum of interfering substance is canceled 19. Accordingly, the
choice of the zero crossing wavelengths selected for calibration
is not critical as in D1 derivative method.
In order to optimize DR1 method for determination of PIM
in presence of its degradation products, it is necessary to test
the inﬂuence of the variables: divisor concentration, smoothing
and scaling factors. Several divisor concentrations of the acidic
and alkaline degradates were tried, the best results was
obtained when using 80 lg mL1 of its acidic degradates and
20 lg mL1 of its alkaline degradates as divisors. Different
smoothing and scaling factors were also tested where a
smoothing factor Dk= 8 nm, and scaling factor = 10 were
suitable to enlarge the signals of PIM to facilitate its
measurement and to diminish error in reading the signal.
DR1 values showed good linearity and reproducibility at
292.5 nm without interference from its acidic or alkaline
degradates, (Figs. 7 and 8).
Linearity of the peak amplitudes of the DR1 curves at both
wavelengths was obtained in range 10–100 lg mL1.
Figure 2 IR spectra of intact PIM [a], acidic degradates [b] and alkaline degradates [c].
Figure 3 Zero order spectra of PIM (––) and acidic degradates
(. . .), (60 lg mL1 each) using methanol as a solvent.
Figure 4 Zero order spectra of PIM (––) and alkaline degradates
(. . .), (60 lg mL1) using methanol as a solvent.
Figure 5 First derivative absorption spectra of PIM (––) and
acidic degradates ( ), (60 lg mL1 each) using methanol as a
solvent.
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In absorbance ratio method (Q-analysis), the primary require-
ment for developing a method for analysis is that the entirespectra should follow the Beer’s law at all wavelengths, which
was fulﬁlled in case of both these drugs. Absorbance ratio
method uses the ratio of absorbances at two selected wave-
lengths,20 one of which is an isoabsorptive point and other
being the k-max of PIM. From the overlain spectrum of the
drug and its alkaline degradate, 242.2 nm (isoabsorptive point)
and 281.7 nm (kmax of PIM) were selected for the determina-
tion of PIM in presence of its alkaline degradation product.
Linear calibration curves were obtained in the range 10–
100 lg mL1 for both intact PIM and its alkaline degradation
products relating the absorbance at the two selected wave-
lengths 242.2 nm and 281.7 nm to the corresponding concen-
trations of PIM and its alkaline degradate and the regression
equations were computed.
The concentration of PIM was determined by substituting
the absorbance and absorptivity coefﬁcients in the following
equation21
Figure 6 First derivative absorption spectra of PIM (––) and
alkaline degradates ( ), (60 lg mL1 each) using methanol as a
solvent.
178 A.M.A.A. Alamein et al.CPIM ¼
Qm Qy
QX Qy
 A1
ax1
;
where A1 and A2 are the absorbances of mixture at 242.2 nm
and 281.7 nm respectively. ax1 and ax2 are the absorptivity
coefﬁcients of PIM at 242.2 nm and 281.7 nm respectively.
While ay1 and ay2 are the absorptivity coefﬁcients of alkaline
degradate at 242.2 nm and 281.7 nm respectively. Qm = A2/
A1, Qy ¼ ay2ay1 and Qx ¼
ax2
ax1
.
3.4. Dual wave length method
The privilege for utility of dual wavelength data processing
program is to calculate the unknown concentration of a com-
ponent of interest independent of the extensively or even com-
pletely interfering components. The only pre-requisite for dual
wavelength method is the selection of two such wavelengths at
which the difference in the analyte signals had to be linear
while the difference in the interferent signal is remaining zero.
The overlain spectrum of PIM and its alkaline degradates sug-
gested that dual wavelength method is a suitable method for
the simultaneous determination of PIM in presence of its alka-
line degradates.22
From the overlain spectra (Fig. 4) 270.1 nm and 284 nm
were selected for the determination of PIM, where the alkaline
degradates shows the same absorbance.
A linear Calibration curve was obtained in the range 10–
100 lg mL1 relating the difference between the absorbances
at the two selected wavelengths 270.1 nm and 284 nm to the
corresponding drug concentrations in presence of alkaline
degradates.
3.5. H-point standard addition analysis method
PIM was also determined and resolved from its alkaline degra-
dates by using H-point standard addition analysis method.Figure 7 First derivative ratio spectra of different concentra-
tions of PIM (10–100 lg mL1) using 80 lg mL1 acidic degra-
dates as a divisor.The H-point standard addition method (HPSAM) permits
both proportional and constant errors produced by the matrix
of the sample to be corrected. This method is based on the
principles of dual wavelength spectrophotometry and the
standard addition method. The method has been applied to
binary mixtures of drugs with overlapped absorption
spectra.23,24. The greatest advantage of HPSAM is that it
can remove the errors resulting from other components in
the system.
HPSAM uses the analytical signal at two accurately
selected wavelengths corresponding to constant absorbance
of interfering substance to be plotted versus the added
analyte concentration. The following principles have to be
followed for selection of appropriate wavelengths for applying
HPSAM:
(i) At two selected wavelengths, the signal of interfering
substance must remain the same, even if the analyte is
changed.
(ii) The analytical signals of the mixture composed of the
analyte and interfering substance should be equal to
the sum of individual signals of the two species.
(iii) The slope difference of the two straight lines obtained at
two selected wavelengths must be as large as possible in
order to get good accuracy.
By plotting the analytical signal against the added analyte
concentration, two straight lines are obtained that have a com-
mon point with coordinates H (–CH, AH), where –CH is the
unknown analyte concentration and AH the analytical signal
due to the interfering species.25
For determination of PIM in presence of its alkaline degra-
date by HPSAM, two wavelengths k1 (270.1 nm) and k2
(284 nm) were selected at which the spectrum of its degrada-
tion products show the same value of absorbance as presented
in Fig. 4.
Different calibrations were plotted for various laboratory
prepared mixtures to assist the accuracy and the speciﬁcity
of the selected pair of wavelengths, for accuracy, different con-
centrations of PIM (10, 20 and 30 lg mL1) were separately
added each to a constant concentration degradation products
(10 lg mL1) to prepare three mixtures containing different
ratios of PIM and its degradation products. To the previously
prepared mixtures, different concentrations of PIM wereFigure 8 First derivative ratio spectra of different concentra-
tions of PIM (10–100 lg mL1) using 20 lg mL1 alkaline degra-
dates as a divisor.
Figure 9 Plots of H-point standard method between the
absorbance at 270.1 nm and 284 nm and the added concentration
of PIM to mixture of PIM and alkaline degradation products
(10 lg mL1each).
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Figure 10 Mean centered ratio spectra of PIM 10–100 lg mL1
in methanol using 20 lg mL1of degradation products as a
divisor.
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were plotted against the added PIM concentrations.
Another set of mixtures were prepared in which PIM con-
centration is constant (10 lg mL1) while the concentration
of the degradation products is variable (10, 20, 40 lg mL1)
to assist the speciﬁcity of the method. Different concentrations
of the previously prepared mixtures and the absorbances at the
two selected wavelengths were plotted against the added PIM
concentration.
Table 3, shows the regression parameters calculated for
each calibration, it is evident from the results that the slopes
at each wavelength were almost equal, and the calculated
recoveries of PIM were satisfactory to assist the accuracy
and speciﬁcity of the selected pair wavelengths.
Samples containing 10 lg mL1 PIM and 10 lg mL1 alka-
line degradates were prepared, then known amounts of PIM
(10, 20, 30, 40, 50, 60, 70, 80 lg) were successively added to
the mixtures and the resulting absorbance at the two selected
wavelengths; k1 (270.1 nm) and k2 (284 nm) at which the degra-
dation products have the same absorbances values.
By plotting the absorbance at selected pair of wavelengths
against added concentration of PIM, two straight lines are
obtained that intersect at so-called H-point (its x axis value
refer to original PIM concentration in the prepared mixture
which is constant while its y axis value corresponds to the
absorbance of the degradation products) as presented in Fig. 9.
A linear correlation was obtained between the absorbance
against added PIM concentration at the two selected wave-
lengths 270.1 nm and 284 nm. The regression equations were
computed and found to be:
A270:1 ¼ 0:0093Cþ 0:145 r ¼ 0:9998
A284 ¼ 0:0138Cþ 0:1902 r ¼ 0:9999
where, A is the absorbance value at the two selected wave-
lengths 270.1 nm and 284 nm, C is the concentration of PIM
in lg mL1 in the mixture and r is the correlation coefﬁcient.
The equation used for the determination of PIM concentra-
tion using the parameters in the last two equations is:
C ¼ ðA270:1  A284Þ=ðMk1 Mk2Þ
To assess the efﬁciency of the proposed method as stability
indicating, it was applied to laboratory prepared mixtures con-
taining different ratios of intact PIM and its alkaline
degradate.Table 3 Results of several experiments for the analysis of Pimozid
HPSAM.
A–C equation R T
P
A270.1 = 0.0093Ci + 0.145 0.9998 1
A284 = 0.0138Ci + 0.1902 0.9999
A270.1 = 0.0093Ci + 0.1988 0.9998 1
A284 = 0.0138Ci + 0.2439 0.9998
A270.1 = 0.0092Ci + 0.32 0.9998 1
A284 = 0.0137Ci + 0.3655 0.9998
A270.1 = 0.0092Ci + 0.2413 0.9997 2
A284 = 0.0138Ci + 0.3309 0.9999
A270.1 = 0.0093Ci + 0.3299 0.9996 3
A284 = 0.0139Ci + 0.4694 0.99983.6. Mean centering method
Mean centering is a recently established spectrophotometric
method that was developed for the simultaneous determina-
tion of binary and ternary mixtures without preliminary sepa-
ration. This method differs from the ratio derivative method ine and its alkaline degradation products in synthetic samples by
aken (lg mL1) Recovery %
IM Alkaline deg. PIM
0 10 102
0 20 100
0 40 102.2
0 10 98.90
0 10 98.53
Table 4 Validation parameters for the proposed stability-indicating spectrophotometric methods.
Validation parameters D1 DR1 Q-analysis method Dual wave
length
HPSAM MC
252 nm 256.3 nm 292.5 nm 292.6 nm 242.1 nm 281.7 nm 270.1 nm 284 nm 284 nm
Linearity (lg mL1) 10–100 10–100 10–100 10–100 10–100 10–100 10–100 10–100
Slope 0.0115 0.031 0.231 1.007 0.0058 0.0142 0.0045 0.0093 0.0138 0.0704
Intercept 0.002 0.011 0.0205 0.24 0.0027 0.0044 0.0002 0.145 0.1902 0.00806
Correlation coeﬃcient (r) 0.9999 0.9999 1 1 0.9998 0.9999 1 0.9998 0.9999 0.9999
LODa (lg mL1) 0.85 1.08 0.72 0.85 1.35 1.16 1.05 1.91 1.91 0.53
LOQa (lg mL1) 2.59 3.3 2.19 2.57 4.11 3.52 0.34 5.8 4.11 1.63
Precision Intra-dayb 0.36 0.36 0.13 0.52 0.12 0.25 0.28 0.15
Inter-dayc 0.46 0.24 0.12 0.92 0.13 0.28 0.31 0.44
a Limits of detection and quantitation are determined via calculations: LOD= (SD of the response/slope)  3.3. LOQ= (SD of the
response/slope)  10.
b The intraday (n= 3) average of three concentrations (30, 50, 70) repeated three times within day.
c The interday (n= 9) average of three concentrations repeated three times in three successive days.
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Figure 11 RMSECV plot of a training set prediction using cross
validation (principal component regression model).
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Figure 12 RMSECV plot of a training set prediction using cross
validation (partial least squares model).
180 A.M.A.A. Alamein et al.that it is based on mean centering of the ratio spectra instead
of calculating their derivative and therefore the signal-to-noise
ratio is enhanced.26 It was used in many applications as kinetic
analysis of binary mixtures27 and determination of reactions’
rate constant.28
As shown in Fig. 4, the absorption spectra of PIM and its
alkaline degradation product in methanol are severely over-
lapped. So, the absorption spectra of the standard solutions
of the PIM with different concentrations (10–100 lg mL1)
were recorded and divided by the spectrum of 20 lg mL1 of
its alkaline degradate to obtain the ratio spectra. The obtained
ratio spectra were mean centered and the calculated mean cen-
tered curves are shown in (Fig. 10).The concentration of PIM
was determined by measuring the amplitude at 284 nm corre-
sponding to a maximum wavelength (Fig. 10). For determina-
tion of the concentration of PIM in laboratory-prepared
mixtures and samples of a pharmaceutical preparation, the
same procedure was used, except that the spectra of the mix-
ture were used instead of those of a standard solution of PIM.
The effect of divisor concentration on analytical parame-
ters, such as slope, intercept, and correlation coefﬁcient of
the calibration graphs was also tested. Different concentra-
tions of divisor were used, but it was observed that changing
the concentration had no signiﬁcant effect on the linear cali-
bration range and calculated analytical parameters.
Results of assay validation obtained by applying the pro-
posed spectrophotometric methods for determination of the
intact PIM in presence of its degradation products are pre-
sented in Table 4.
3.7. Multivariate method
In this section, different chemometric approaches were applied
for the determination of PIM in presence of its acidic and alka-
line degradates, including CLS, PCR, PLS. these multivariate
calibrations were useful in spectral analysis because the simul-
taneous inclusion of many spectral wavelengths instead of sin-
gle wavelength greatly improved the precision and predictive
ability.29
The ﬁrst step in the simultaneous determination of ternary
components by multivariate calibration methods involves
constructing the calibration matrix for ternary mixture. Thecalibration set was obtained by using the absorption spectra
of a set of 16 mixtures of PIM and both of its degradation
products with different ratios of each component and their
concentrations as given in Table 1. Different concentrations
of PIM and both its acidic and alkaline degradates were used
in the validation set, Table 2.
The UV spectra of the prepared solutions were recorded
over the range 240–370 nm. Wavelengths (200–239 nm)
Table 5 Results of assay validation obtained by applying the
proposed chemometric methods for the determination of
Pimozide in presence of both its acidic and alkaline degradates.
Validation parameters CLS PCR PLS
Predicted versus actual concentration plot
Slope 1.000 1.001 0.9999
Intercept 0.00028 0.0011 0.0081
Correlation coeﬃcient (r) 1.000 1.000 1.000
RMSEP 0.0030 0.0028 0.0072
Univariate spectrophotometry and multivariate calibration 181dominated by noise and non informative spectral region after
370 nm are not included. Spectra were digitized each at 0.1 nm
interval, and the experimental data points were exposed to
MATLAB_version 7.0 for calculations.
To build the CLS model, feed the computer with absor-
bance and concentration matrices for training set. Carry out
the calculations to obtain the ‘‘K” matrix. For the PCR and
PLS models, use the training set absorbance and concentration
matrices together with PLS-Toolbox 2.0 software for the
calculations.Table 6 Determination of the studied drug in the laboratory prepar
the proposed methods.
Sample D1-methoda DR1-methoda Q-
analysis
methoda
252 nm 256.3 nm 292.5 nm 292.6 nm
L.P.-mixtures
(n= 5)b
98.84
± 0.72
99.88
± 0.93
100.23
± 0.51
101.22
± 0.44
100.64
± 0.68
Standard error
of mean
0.322 0.416 0.228 0.197 0.304
Variance 0.518 0.865 0.260 0.194 0.462
Orape-forte
tablets 4 mg,
B.N. 12Q019
101.41
± 0.20
101.09
± 0.34
101.22
± 0.28
101.23
± 0.14
100.02
± 0.16
Standard error
of mean
0.089 0.152 0.125 0.063 0.072
Variance 0.0004 0.116 0.078 0.0196 0.026
a Recovery ±SD.
b Sets each of 3 replicates.
Table 7 Application of the standard addition technique to the ana
Pharmaceutical
preparation
Authentic
added
(lg mL1)
Standard addition
Recovery%*
D1 DR1
252 nm 256.3 nm 292.5 nm 292.6 n
Orape-forte
tablets 4 mg
B.N. 12Q019
20 102.56 98.54 99.68 101.40
30 102.57 99.89 101.27 101.75
40 100.63 99.83 100.12 101.20
50 101.20 100.58 102.82 101.64
60 100.42 99.83 100.08 100.72
Mean 101.47 99.73 100.97 101.34
SD 1.03 0.73 1.27 0.41
* Average of at least 3 separate determinations.The selection of the optimum number of factors for the PLS
technique was a very important step before constructing the
models because if the number of factors retained was more
than the required, more noise will be added to the data. On
the other hand, if the number retained was too small meaning-
ful data that could be necessary for the calibration might be
discarded. In this study the leave one out cross validation
method was used.30,31 Two factors were found to be suitable
for both PLS and PCR methods (Figs. 11 and 12).
The root mean square error of prediction (RMSEP) was
calculated as diagnostic tool for examining the errors in the
predicted concentrations. It indicated both the precision and
accuracy of predictions as it played the same role of standard
deviation in indicating the spread of the concentration errors.
Results of assay validation parameters obtained by apply-
ing the proposed chemometric methods for the determination
of PIM in presence of its acidic and alkaline degradation prod-
ucts were calculated and listed in Table 5.
The proposed spectrophotometric and chemometric meth-
ods were applied successfully for the determination of PIM
in presence of its acidic and alkaline degradates in different
laboratory prepared mixtures and in pharmaceutical formula-
tion. The results obtained are listed in Table 6.ed (L.P.) mixtures with its degradation products and in tablets by
Dual wave
length
methoda
HPSAMa MCa CLSa PCRa PLSa
100.61
± 0.30
100.38
± 0.34
100.78
± 0.56
99.99
± 0.0078
100.00
± 0.0070
99.99
± 0.0183
0.134 0.152 0.250 0.0035 0.0031 0.0082
0.09 0.116 0.314 0.00006 0.00005 0.0003
99.65
± 0.13
99.77
± 0.30
99.88
± 0.26
100.20
± 0.19
100.25
± 0.15
100.27
± 0.33
0.058 0.134 0.116 0.085 0.067 0.148
0.017 0.09 0.068 0.008 0.023 0.109
lysis of the studied drug by the proposed methods.
Q-
analysis
Dual
wave
length
HPSAM MC CLS PCR PLS
m
99.88 102.77 101.61 98.92 99.20 99.50 99.75
99.48 101.11 100.33 100.80 100.06 99.80 99.76
99.62 101.38 10.80 100.28 100.30 100.42 100.42
99.77 101.55 101.08 101.77 99.76 99.68 99.84
99.80 101.29 100.90 101.09
99.71 101.62 100.94 100.57 99.83 99.85 99.94
1.15 0.66 0.46 1.06 0.47 0.40 0.32
Table 8 Statistical comparison of the results obtained by the proposed methods and the manufacturer method for the determination
of Pimozide in pharmaceutical preparation.
Items D1 DR1 Q-analyss Dual
wave length
HPSAM MC CLS PCR PLS Reported method*
252 nm 256.3 nm 292.5 nm 292.6 nm
Mean 101.41 100.09 101.22 101.23 100.02 99.65 99.77 99.88 100.20 100.25 100.27 100.09
SD 0.20 0.34 0.28 0.14 0.16 0.13 0.30 0.16 0.19 0.13 0.13 0.14
RSD% 0.19 0.33 0.27 0.14 0.15 0.13 0.30 0.16 0.18 0.12 0.12 0.13
n 5 5 5 5 5 5 5 5 5 5 5 5
Variance 0.046 0.122 0.08 0.021 0.030 0.017 0.09 0.02 0.03 0.02 0.018 0.02
Student’s t-test
(2.306)
0.85 2.14 1.83 2.03 0.66 1.80 2.08 2.14 1.03 1.80 2.05
F-test (6.388) 2.03 4.89 4.11 1.07 1.39 1.14 4.62 1.33 1.81 1.03 1.08
The values between parenthesis are the theoretical values of t-test and F-test at P= 0.05.
* HPLC system using C18, a mobile phase consisting methanol: phosphate buffer (8.1) (85:15) and UV detection at 254 nm.
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Table 9 One-way ANOVA testing for the different proposed
methods used for the determination of Pimozide.
Source of
variation
Sum of
squares
(SS)
Degree of
freedoma
(df)
Mean
squares
(MS)
F-valueb F-critical
Between
groups
8.527028 10 0.852703 1.614337 2.070965
Within
groups
21.65646 41 0.528206
Total 30.18348 51
a At the 0.05 level.
b The population means are not signiﬁcantly different.
182 A.M.A.A. Alamein et al.To assess the accuracy of the all proposed methods devel-
oped in this work, standard addition technique was carried
out and satisfactory results were obtained, Table 7. A statisti-
cal comparison of the results obtained by the suggested meth-
ods and the ofﬁcial non aqueous titration3 for the
determination of pure drug was done. The values of calculated
t and F-values are less than the tabulated ones,32, which reveals
that there is no signiﬁcant difference with respect to accuracy
and precision between the proposed methods and the reported
one, Table 8. In order to compare the ability of the proposed
methods for the determination of PIM, the results obtained by
applying the proposed methods were subjected to statistical
analysis using a one-way analysis of variance (ANOVA) test;
there was no signiﬁcant difference among all of the proposed
methods as shown in Table 9.
4. Conclusion
The proposed methods are simple, very sensitive, precise, and
can be easily applied in QC laboratories for determination of
PIM in presence of its acidic and alkaline degradates. The pre-
sented work has advantages over the published stability study
HPTLC work9 of being simple, needs no such drastic organic
solvent system consisting of toluene: acetone: ammonia; using
simple spectrophotometer which is available in all quality con-
trol labs; and our work suggested many alternative methods to
facilitate the quantitative determination of PIM.
The proposed methods could be also successfully applied
for routine analysis of PIM either in its bulk powder or indosage form in QC laboratories, without any preliminary
separation step.
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